High-intensity focused ultrasound ablation as a treatment for benign thyroid diseases: the present and future
- PMID: 30690961
- PMCID: PMC6443589
- DOI: 10.14366/usg.18040
High-intensity focused ultrasound ablation as a treatment for benign thyroid diseases: the present and future
Abstract
High-intensity focused ultrasound (HIFU) is a promising ablation technique for benign thyroid nodules. Current evidence has found good short- to medium-term outcomes, similar to those of better-established ablation techniques such as radiofrequency and laser ablation. The fact that it does not require insertion of a needle into the target makes HIFU a truly non-invasive treatment. Although it is not without risks, its low risk profile makes it an attractive alternative to surgery. There is much room for future development, starting from expanding the current indications to enhancing energy delivery. Relapsed Graves disease and papillary microcarcinoma are diseases that can benefit from HIFU treatment. Its role in the mediation of immune responses and synergistic effects with immunotherapy are promising in the fight against metastatic cancers.
Keywords: Ablation techniques; Goiter, nodular; High-intensity focused ultrasound ablation; Hyperthermia, induced; Ultrasonography, interventional.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
References
-
- Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedus L, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: 2016 update. Endocr Pract. 2016;22:622–639. - PubMed
-
- Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1–133. - PMC - PubMed
-
- Lee L, Mitmaker EJ, Chabot JA, Lee JA, Kuo JH. Cost-effectiveness of diagnostic lobectomy versus observation for thyroid nodules >4 cm. Thyroid. 2016;26:271–279. - PubMed
-
- Durante C, Costante G, Lucisano G, Bruno R, Meringolo D, Paciaroni A, et al. The natural history of benign thyroid nodules. JAMA. 2015;313:926–935. - PubMed
-
- Bergenfelz A, Jansson S, Kristoffersson A, Martensson H, Reihner E, Wallin G, et al. Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Langenbecks Arch Surg. 2008;393:667–673. - PubMed
LinkOut - more resources
Full Text Sources
